Company page

Coherus Oncology, Inc.

Coherus Oncology, Inc. (Ticker: CHRS) is a public company based in the United States, focusing on the development and commercialization of innovative oncology therapeutics. With a market capitalization of approximately $228.3 million, Coherus aims to address unmet needs in cancer treatment through its advanced product pipeline. The company is committed to improving patient outcomes and enhancing the quality of life for those affected by cancer.